Molecular Insight Pharmaceuticals, Inc. (MIPI)

CAPS Rating:

A biopharmaceutical company focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics designed to improve patient diagnosis, treatment and management.